** GenScript Biotech jumps as much as 7.2% to HK$10.98, highest since Dec. 11, 2024
** Stock set for biggest one-day pct rise since Oct. 22, 2024 and is on course for sixth consecutive session of gains
** Co's associate Legend Biotech announces its drug CARVYKTI, used to treat cancer of the bone marrow, brought in ~$334 mln in net trade sales in quarter ended Dec. 31, 2024, up from year-ago $159 mln
** GenScript fell 50.5% last year
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。